ScopeSys closes a $1.1 million seed funding round to enhance tools for drugmakers, providing insights into genomic medicines.
Amount Raised
C$1.1 Million
Round Type
Seed
VancouverManufacturingBiotechnologyDescription
Vancouver-based ScopeSys has successfully secured $1.1 million in seed funding. The startup, founded in 2017, aims to improve the development of genomic medicines with its innovative technologies. CEO Padma Kodukula highlights the need for enhanced analytical instruments in the industry. This funding will help accelerate the development of their cutting-edge tools.
Quick answer
ScopeSys raised C$1.1 Million in a Seed round, dated August 14, 2026. ScopeSys is based in Vancouver, British Columbia, Canada.
- How much did ScopeSys raise?
- ScopeSys raised C$1.1 Million in a Seed round on August 14, 2026.
- What does ScopeSys do?
- ScopeSys is a Vancouver, BC startup founded in 2017 that focuses on developing next-generation analytical instruments for genomic medicines.
- Where is ScopeSys based and how big is it?
- ScopeSys is based in Vancouver, British Columbia, Canada.
Source: Fundz verified event record.
Who to call at ScopeSys, and when
A new round usually means ScopeSys is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day ScopeSys raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at ScopeSys, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at ScopeSys. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment ScopeSys raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
ScopeSys raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.